AGILE THERAPEUTICS INC (AGRX) Forecast, Price Target & Analyst Ratings

NASDAQ:AGRX • US00847L3087

Current stock price

0.6022 USD
+0.06 (+10.11%)
At close:
0.2408 USD
-0.36 (-60.01%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AGILE THERAPEUTICS INC (AGRX).

Forecast Snapshot

Consensus Price Target

Price Target
$5.10
+ 746.89% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 9, 2024
Period
Q1 / 2024
EPS Estimate
-$0.52
Revenue Estimate
3.827M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$5.10
Upside
+ 746.89%
From current price of $0.60 to mean target of $5.10, Based on 7 analyst forecasts
Low
$5.05
Median
$5.10
High
$5.25

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for AGRX. The average price target is 5.1 USD. This implies a price increase of 746.89% is expected in the next year compared to the current price of 0.6022.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

AGRX Current Analyst RatingAGRX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

AGRX Historical Analyst RatingsAGRX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
AGRX was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about AGRX.
In the previous month the buy percentage consensus was at a similar level.
AGRX was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-03-18Maxim GroupDowngrade Buy -> Hold
2023-09-22Maxim GroupUpgrade Hold -> Buy
2023-06-26HC Wainwright & Co.Reiterate Buy -> Buy
2023-06-07HC Wainwright & Co.Reiterate Buy -> Buy
2022-12-30HC Wainwright & Co.Maintains Buy
2022-07-26Maxim GroupUpgrade Hold -> Buy
2022-07-11HC Wainwright & Co.Maintains Buy
2022-04-08Maxim GroupDowngrade Buy -> Hold
2021-11-03HC Wainwright & Co.Maintains Buy
2021-09-13HC Wainwright & Co.Maintains Buy
2021-07-27RBC CapitalMaintains Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 9, 2024
Period
Q1 / 2024
EPS Estimate
-$0.52
Revenue Estimate
3.827M
Revenue Q2Q
0.45%
EPS Q2Q
91.20%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
-55.77%
Revenue (3 Months)
-55.77%
EPS (1 Month)
-70.37%
EPS (3 Months)
-70.37%

Next Earnings Summary

AGRX is expected to report earnings on 5/9/2024. The consensus EPS estimate for the next earnings is -0.52 USD and the consensus revenue estimate is 3.83M USD.
The next earnings revenue estimate has been revised downward by 55.77% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2024 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
AGRX revenue by date.AGRX revenue by date.
750K4.1M
446.67%		10.88M
165.37%		20.448M
87.94%		37.575M
83.76%		51.95M
38.26%		67.614M
30.15%		112.1M
65.79%		163.72M
46.05%		143.76M
-12.19%		120.78M
-15.98%
EBITDA
YoY % growth
AGRX ebitda by date.AGRX ebitda by date.
-48.77M
-160.80%		-68.79M
-41.05%		-39.91M
41.98%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
AGRX ebit by date.AGRX ebit by date.
-49.05M
-160.07%		-71.01M
-44.77%		-41.44M
41.64%		-18.248M
55.97%		2.642M
114.48%		15.524M
487.59%		29.734M
91.54%		53.296M
79.24%		99.719M
87.10%		81.139M
-18.63%		60.074M
-25.96%
Operating Margin
AGRX operating margin by date.AGRX operating margin by date.
-6,540.00%-1,731.95%-380.88%-89.24%7.03%29.88%43.98%47.54%60.91%56.44%49.74%
EPS
YoY % growth
AGRX eps by date.AGRX eps by date.
-24.00
-53.85%		-423.20
-1,663.33%		N/A
69.87%		-7.75
92.28%		0.67
106.84%		1.69
151.52%		1.44
-15.06%		2.58
79.43%		10.32
300.00%		8.08
-21.74%		5.73
-29.04%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.52
91.20%		-0.32
85.29%		-0.10
62.22%		0.02
101.35%
Revenue
Q2Q % growth		3.827M
0.45%		5.741M
4.38%		7.654M
14.92%		8.611M
107.49%
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-3.569M
46.81%		-2.157M
57.95%		-709.92K
82.25%		123.42K
103.81%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

AGRX Yearly Revenue VS EstimatesAGRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
AGRX Yearly EPS VS EstimatesAGRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -500 -1K

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
26.27%
EPS Next 5 Year
15.10%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
72.20%
Revenue Next 5 Year
61.60%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

AGILE THERAPEUTICS INC / AGRX Forecast FAQ

Can you provide the average price target for AGILE THERAPEUTICS INC stock?

7 analysts have analysed AGRX and the average price target is 5.1 USD. This implies a price increase of 746.89% is expected in the next year compared to the current price of 0.6022.

What is the next earnings date for AGRX stock?

AGILE THERAPEUTICS INC (AGRX) will report earnings on 2024-05-09, before the market open.

What are the consensus estimates for AGRX stock next earnings?

The consensus EPS estimate for the next earnings of AGILE THERAPEUTICS INC (AGRX) is -0.52 USD and the consensus revenue estimate is 3.83M USD.

What is the consensus rating for AGILE THERAPEUTICS INC (AGRX) stock?

The consensus rating for AGILE THERAPEUTICS INC (AGRX) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.